Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19

Russell, Clark D, Valanciute, Asta, Gachanja, Naomi N, Stephen, Jillian, Penrice-Randal, Rebekah ORCID: 0000-0002-0653-2097, Armstrong, Stuart D ORCID: 0000-0002-3862-1801, Clohisey, Sara, Wang, Bo, Al Qsous, Wael, Wallace, William A
et al (show 9 more authors) (2022) Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 66 (2). pp. 196-205.

Access the full-text of this item by clicking on the Open Access link.


Immunopathology occurs in the lung and spleen in fatal coronavirus disease (COVID-19), involving monocytes/macrophages and plasma cells. Antiinflammatory therapy reduces mortality, but additional therapeutic targets are required. We aimed to gain mechanistic insight into COVID-19 immunopathology by targeted proteomic analysis of pulmonary and splenic tissues. Lung parenchymal and splenic tissue was obtained from 13 postmortem examinations of patients with fatal COVID-19. Control tissue was obtained from cancer resection samples (lung) and deceased organ donors (spleen). Protein was extracted from tissue by phenol extraction. Olink multiplex immunoassay panels were used for protein detection and quantification. Proteins with increased abundance in the lung included MCP-3, antiviral TRIM21, and prothrombotic TYMP. OSM and EN-RAGE/S100A12 abundance was correlated and associated with inflammation severity. Unsupervised clustering identified "early viral" and "late inflammatory" clusters with distinct protein abundance profiles, and differences in illness duration before death and presence of viral RNA. In the spleen, lymphocyte chemotactic factors and CD8A were decreased in abundance, and proapoptotic factors were increased. B-cell receptor signaling pathway components and macrophage colony stimulating factor (CSF-1) were also increased. Additional evidence for a subset of host factors (including DDX58, OSM, TYMP, IL-18, MCP-3, and CSF-1) was provided by overlap between <i>1</i>) differential abundance in spleen and lung tissue; <i>2</i>) meta-analysis of existing datasets; and <i>3</i>) plasma proteomic data. This proteomic analysis of lung parenchymal and splenic tissue from fatal COVID-19 provides mechanistic insight into tissue antiviral responses, inflammation and disease stages, macrophage involvement, pulmonary thrombosis, splenic B-cell activation, and lymphocyte depletion.

Item Type: Article
Uncontrolled Keywords: COVID-19, inflammation, lung, macrophages, proteomics
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Infection, Veterinary and Ecological Sciences
Depositing User: Symplectic Admin
Date Deposited: 16 May 2022 07:55
Last Modified: 18 Jan 2023 21:02
DOI: 10.1165/rcmb.2021-0358OC
Open Access URL: https://doi.org/10.1165/rcmb.2021-0358OC
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3154851